Lucid Diagnostics Inc. (LUCD) Tops Q3 EPS by 7c

Lucid Diagnostics Inc. (NASDAQ: LUCD) reported Q3 EPS of ($0.28), $0.07 better than the analyst estimate of ($0.35). Revenue for the quarter came in at $80 thousand versus the consensus estimate of $431.38 thousand.

For earnings history and earnings-related data on Lucid Diagnostics Inc. (LUCD) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Primoris cuts 2026 outlook on renewables cost overruns, COO exits
• Ennis (EBF) Reports In-Line Q1 EPS